Eurofins Scientific to Acquire EAG Labs
PTSM: Pharmaceutical Technology Sourcing and Management
Eurofins Scientific has announced an agreement to acquire EAG Laboratories to expand its reach in North America.
On Sept. 18, 2017, Eurofins Scientific, a life sciences company specializing in analytical testing, announced that it has entered into an agreement to acquire EAG Laboratories, a scientific services company specializing in analytical and testing services to the agrochemical and pharmaceutical industries, from Odyssey Investment Partners. The transaction is expected to close within a few months following this announcement, subject to the fulfillment of customary closing conditions.
This acquisition by Eurofins Scientific is the latest move in a recent series of transitions for EAG Labs. In July 2015, EAG (Evans Analytical Group), a scientific services company that serves technology- and life-science-related industries, acquired Analytical Bio-Chemistry Laboratories (ABC Laboratories), which it later rebranded as EAG Labs in July 2016. With this acquisition, Eurofins Scientific aims to expand its reach in North America.
“We are extremely pleased to welcome EAG and its talented teams to the Eurofins Group. EAG’s competencies, reputation for scientific excellence, and footprint further strengthen Eurofins’ global offering in the highly attractive biopharmaceutical and agroscience testing markets with perfect geographic complementarity,” said Dr. Gilles Martin, Eurofins CEO, in a company press release. “In addition, EAG provides Eurofins with an entirely new business line and growth market in material sciences. We look forward to strengthening their portfolio and operating footprint by providing access to the full range of services and capabilities of the Group.”
Source: Eurofins
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
